ATE232108T1 - Interleukin - 8 als antivirale- und antitumorwirkstoffe - Google Patents
Interleukin - 8 als antivirale- und antitumorwirkstoffeInfo
- Publication number
- ATE232108T1 ATE232108T1 AT97929060T AT97929060T ATE232108T1 AT E232108 T1 ATE232108 T1 AT E232108T1 AT 97929060 T AT97929060 T AT 97929060T AT 97929060 T AT97929060 T AT 97929060T AT E232108 T1 ATE232108 T1 AT E232108T1
- Authority
- AT
- Austria
- Prior art keywords
- interleukin
- antiviral
- actives
- antitumor
- antitumor actives
- Prior art date
Links
- 102000004890 Interleukin-8 Human genes 0.000 title abstract 3
- 108090001007 Interleukin-8 Proteins 0.000 title abstract 3
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 title abstract 3
- 229940096397 interleukin-8 Drugs 0.000 title abstract 3
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 230000000840 anti-viral effect Effects 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2053—IL-8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/141—Interleukin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/674,633 US5900235A (en) | 1996-07-05 | 1996-07-05 | Interleukin-8 as an antiviral and antitumor agent |
| PCT/CA1997/000479 WO1998001150A1 (en) | 1996-07-05 | 1997-07-04 | Interleukin-8 as an antiviral and antitumor agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE232108T1 true ATE232108T1 (de) | 2003-02-15 |
Family
ID=24707360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97929060T ATE232108T1 (de) | 1996-07-05 | 1997-07-04 | Interleukin - 8 als antivirale- und antitumorwirkstoffe |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5900235A (de) |
| EP (1) | EP0909178B1 (de) |
| JP (1) | JP2000514066A (de) |
| KR (1) | KR20000023562A (de) |
| AT (1) | ATE232108T1 (de) |
| AU (1) | AU713675B2 (de) |
| BR (1) | BR9710206A (de) |
| CA (1) | CA2258697A1 (de) |
| DE (1) | DE69718911T2 (de) |
| ES (1) | ES2191842T3 (de) |
| NZ (1) | NZ333605A (de) |
| WO (1) | WO1998001150A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7244349B2 (en) | 1997-12-17 | 2007-07-17 | Molecular Devices Corporation | Multiaperture sample positioning and analysis system |
| US20020144905A1 (en) | 1997-12-17 | 2002-10-10 | Christian Schmidt | Sample positioning and analysis system |
| US7067046B2 (en) | 2000-08-04 | 2006-06-27 | Essen Instruments, Inc. | System for rapid chemical activation in high-throughput electrophysiological measurements |
| US7270730B2 (en) | 2000-08-04 | 2007-09-18 | Essen Instruments, Inc. | High-throughput electrophysiological measurement system |
| US6962971B2 (en) * | 2001-03-16 | 2005-11-08 | The Regents Of The University Of California | Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts |
| AU2003287217B2 (en) | 2002-10-24 | 2010-03-04 | Paratek Pharmaceuticals, Inc. | Methods of using substituted tetracycline compounds to modulate RNA |
| US20070082068A1 (en) * | 2003-11-25 | 2007-04-12 | Hideo Satsu | Il-8 production promoters and use thereof |
| KR20230086610A (ko) | 2021-12-07 | 2023-06-15 | 재단법인 아산사회복지재단 | Il-12를 발현하는 재조합 백시니아 바이러스 및 이의 용도 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996009062A1 (en) * | 1994-09-23 | 1996-03-28 | University Of Nebraska Board Of Regents | Polypeptide agonists and antagonists of human interleukin-8 |
-
1996
- 1996-07-05 US US08/674,633 patent/US5900235A/en not_active Expired - Lifetime
-
1997
- 1997-07-04 AU AU33314/97A patent/AU713675B2/en not_active Ceased
- 1997-07-04 ES ES97929060T patent/ES2191842T3/es not_active Expired - Lifetime
- 1997-07-04 CA CA002258697A patent/CA2258697A1/en not_active Abandoned
- 1997-07-04 WO PCT/CA1997/000479 patent/WO1998001150A1/en not_active Ceased
- 1997-07-04 DE DE69718911T patent/DE69718911T2/de not_active Expired - Fee Related
- 1997-07-04 BR BR9710206A patent/BR9710206A/pt not_active IP Right Cessation
- 1997-07-04 NZ NZ333605A patent/NZ333605A/xx unknown
- 1997-07-04 AT AT97929060T patent/ATE232108T1/de not_active IP Right Cessation
- 1997-07-04 EP EP97929060A patent/EP0909178B1/de not_active Expired - Lifetime
- 1997-07-04 JP JP10504609A patent/JP2000514066A/ja active Pending
-
1999
- 1999-01-04 KR KR1019997000005A patent/KR20000023562A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2258697A1 (en) | 1998-01-15 |
| AU713675B2 (en) | 1999-12-09 |
| NZ333605A (en) | 2000-12-22 |
| DE69718911T2 (de) | 2003-12-24 |
| BR9710206A (pt) | 1999-08-10 |
| US5900235A (en) | 1999-05-04 |
| DE69718911D1 (de) | 2003-03-13 |
| WO1998001150A1 (en) | 1998-01-15 |
| EP0909178B1 (de) | 2003-02-05 |
| KR20000023562A (ko) | 2000-04-25 |
| JP2000514066A (ja) | 2000-10-24 |
| AU3331497A (en) | 1998-02-02 |
| ES2191842T3 (es) | 2003-09-16 |
| EP0909178A1 (de) | 1999-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1027359T3 (da) | Monocykliske L-nukleosider, analoger og anvendelser deraf | |
| BRPI0411900A (pt) | compostos antivirais e métodos | |
| NO963239D0 (no) | Klorpyrimid-mellomprodukter | |
| FI953717L (fi) | 4-Hydroksibentsopyran-2-oneja ja 4-hydroksisykloalkyyli(b)pyran-2-oneja, joita voidaan käyttää retrovirusinfektioiden hoitamiseen | |
| FI20001231A7 (fi) | 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina | |
| EP0676954A4 (de) | Hiv-lockvirus. | |
| EA200000840A1 (ru) | Антивирусные производные пиримидина | |
| ATE219366T1 (de) | Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b | |
| KR950700298A (ko) | 뉴클레오시드 치료제(Therapeutic Nucleosides) | |
| ATE346651T1 (de) | Nucleoside mit anti-hepatitis b virus wirksamkeit | |
| ATE185483T1 (de) | Antivirale nucleosidkombination | |
| PT87039A (pt) | Treatment of human viral infections by dsrna combined with viral inhibitors | |
| ATE249219T1 (de) | Antivirale verbindungen | |
| DK0745852T3 (da) | Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi | |
| PT1280813E (pt) | Analogos de nucleosidos de pirimidina antivirais | |
| UA29466C2 (uk) | Фармацевтична композиція з антипухлинною активністю | |
| ES2123048T3 (es) | Analogos de nucleosidos antiviricos. | |
| ATE232108T1 (de) | Interleukin - 8 als antivirale- und antitumorwirkstoffe | |
| TR200401363T4 (tr) | DNA viral enfeksiyonlarının tedavisi | |
| ATE267198T1 (de) | Synthese und anti-hiv und anti-hepatitis virus aktivität von 1,3-oxaselenolan nucleosiden | |
| ATE147746T1 (de) | Derivate von fluorphosphonat-nukleotiden | |
| MX9201288A (es) | Metodo de tratamiento. | |
| DE69104619D1 (de) | Verwendungsmethoden von humanem Gammainterferon 4-134. | |
| EP0316592A3 (de) | 3'-Fluor-2',3'-dideoxyuridin und seine therapeutische Verwendung | |
| BR0109345A (pt) | Compostos com atividade anti-hiv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0909178 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |